XML 35 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
2025 Notes
Series E preferred shares
Series E preferred shares
2025 Notes
Series E Preferred Stock in Lieu of Interest
Preferred Stock
Preferred Stock
Series E preferred shares
Preferred Stock
Series E Preferred Stock in Lieu of Interest
Common Stock
Common Stock
2025 Notes
Additional Paid-in Capital
Additional Paid-in Capital
2025 Notes
Additional Paid-in Capital
Series E preferred shares
Additional Paid-in Capital
Series E preferred shares
2025 Notes
Additional Paid-in Capital
Series E Preferred Stock in Lieu of Interest
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance, shares (in shares) at Dec. 31, 2019           10     81,974                  
Beginning balance at Dec. 31, 2019 $ (37,358)         $ 0     $ 82   $ 584,862         $ (618,303) $ (3,879) $ (120)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss (111,186)                             (111,215)   29
Foreign currency translation adjustment (3,093)                               (3,093)  
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (in shares)                 2,081                  
Exercise of stock options, vesting of restricted stock units (RSUs) and stock issued under employee stock purchase plan (ESPP) 5,422               $ 2   5,420              
Taxes withheld on net settled vesting of RSUs (354)                   (354)              
Issuance of shares (in shares)             25 2                    
Issuance of shares     $ 25,000   $ 2,330               $ 25,000   $ 2,330      
Stock repurchased (in shares)           (2)                        
Repurchase of Series E preferred stock (2,354)                   (2,354)              
Issuance of common shares in connection with conversion or exchange of notes (in shares)                 13,739 1,177                
Issuance of common shares in connection with conversion or exchange of notes 66,088     $ 14,354         $ 14 $ 1 66,074     $ 14,353        
Exercise of warrants (in shares)                 338                  
Exercise of warrants 1,861                   1,861              
Share-based compensation 10,419                   10,419              
Series E preferred stock dividends 0                   2,904         (2,904)    
Issuance of common shares under settlement (in shares)                 90                  
Issuance of common shares under settlement agreement (972)                   (972)              
Ending balance, shares (in shares) at Dec. 31, 2020           35     99,399                  
Ending balance at Dec. 31, 2020 (27,899)         $ 0     $ 99   711,487         (732,422) (6,972) (91)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss (47,911)                             (48,125)   214
Foreign currency translation adjustment (3,167)                               (3,167)  
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (in shares)                 2,512                  
Exercise of stock options, vesting of restricted stock units (RSUs) and stock issued under employee stock purchase plan (ESPP) 4,765               $ 2   4,763              
Taxes withheld on net settled vesting of RSUs (1,279)                   (1,279)              
Divestiture of Ctrack South Africa (889)                   8         (2,497) 1,608 (8)
Issuance of shares (in shares)                 1,516                  
Issuance of shares 29,370               $ 2   29,368              
Issuance of common shares in connection with conversion or exchange of notes (in shares)           10     1,525 429                
Issuance of common shares in connection with conversion or exchange of notes 0 $ 5,382             $ 2   1,102 $ 5,382       (1,104)    
Net noncontrolling interest acquired 125                             240   (115)
Share-based compensation 16,649                   16,649              
Series E preferred stock dividends 0                   3,139         (3,139)    
Ending balance, shares (in shares) at Dec. 31, 2021           25     105,381                  
Ending balance at Dec. 31, 2021 (24,854)         $ 0     $ 105   770,619         (787,047) (8,531) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss (67,969)                                  
Foreign currency translation adjustment 2,202                               2,202  
Adjustment relating to extinguishment of 2022 Notes 1,728                                  
Exercise of stock options, vesting of restricted stock units and stock issued under employee stock purchase plan (in shares)                 3,092                  
Exercise of stock options, vesting of restricted stock units (RSUs) and stock issued under employee stock purchase plan (ESPP) $ 1,190               $ 3   1,187              
Taxes withheld on net settled vesting of RSUs (in shares) (5)                                  
Taxes withheld on net settled vesting of RSUs $ (290)                   (290)              
Share-based compensation 17,875                   17,875              
Series E preferred stock dividends 0                   2,736         (2,736)    
Ending balance, shares (in shares) at Dec. 31, 2022           25     108,468                  
Ending balance at Dec. 31, 2022 $ (70,118)         $ 0     $ 108   $ 793,855         $ (857,752) $ (6,329) $ 0